Expert's Opinion
-
Clinical Trials
The Future of Clinical Trials Series: Part I
What will 2021 have in store for an industry in flux?Alison Holland, Head of Decentralized Trials, Medable, Maria Fotiu, Executive Director of Decentralized Solutions, Syneos Health 01.19.21
-
Clinical Trials | Drug Development | Information Technology
Virtual Clinical Trials: The Future of Dermatology Studies
COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21
-
Clinical Trials | Drug Development
The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs
Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21
-
Drug Development | Industry News | Regulatory Affairs
The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups 01.05.21
-
Cold Chain Management | Logistics
COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge
How the air cargo logistics community is embracing technology to close critical gaps in the cold chain.Chris Jones, EVP, Marketing and Services, Descartes 12.15.20
-
Clinical Trials | Information Technology
Life Sciences Strive for Greater Agility
Embracing real-time drug safety monitoring during and post COVID will continue to propel the industry forward.Ronan Brown, SVP of Integrated Technology & Compliance, and Joe Rymsza, VP, Global PV & Regulatory Technology Solutions, IQVIA 12.14.20
-
Clinical Trials | Drug Development | Information Technology
Advances in Intelligent Automation
The future of medicine relies on further digital transformation and automation-enabling solutions to improve drug development and monitoring.Updesh Dosanjh, Practice Leader, Technology Solutions, IQVIA 12.14.20
-
Drug Development
Navigating Uncertainty: Considerations for Life Sciences 2021
With vaccines against COVID-19 on the horizon, our focus is shifting to 2021 and the major issues life sciences companies face and reasons for optimism.Arda Ural , EY Americas Health Sciences and Wellness Industry Leader, Ernst & Young LLP 12.11.20
-
Information Technology | Supply Chain
The Pandemic & The Pharma Industry: 3 Things to Know
The importance of vendor contract visibility, an increase in intense legal scrutiny, and new technology for greater agility and control.Colin Earl, CTO at Agiloft 11.16.20
-
Clinical Trials | Information Technology
AI and Advanced Analytics
Equipped with the right tools, CROs are better positioned to develop optimal protocols, rapidly identify patients to enroll, and preempt study issues.Paul Oliver, Medidata 11.13.20
-
Clinical Trials | Information Technology
eCOA: Addressing Barriers to Faster Deployment in Clinical Trials
Clinical Outcome Assessments are an increasingly important tool in clinical research.Paul O'Donohoe, Scientific Lead, eCOA and Mobile Health, Medidata 11.13.20
-
Preparing to Adopt Intelligent Label Management
The labeling process is highly complex and constantly in flux, making it ideal for digital transformation, but AI and ML cannot be implemented overnight.Kiran Chinnalla, Associate Director Global Regulatory Affairs, Julian Backhouse, Associate Director Regulatory Technology Product Management, Cham Williams, Associate Director Business Systems , IQVIA 11.13.20
-
Biologics, Proteins, Vaccines | Cold Chain Management | Logistics | Supply Chain
Rising to The Occasion: The High Stakes of Vaccine Transport
How logistical precision can ensure safe and efficient delivery of the COVID-19 vaccine.Bill Brooks, Vice President of North America Transportation Portfolio at Capgemini 11.04.20
-
Clinical Trials | Information Technology
Adding Remote Site Access to Sponsor Bids: What to Know as CRO
Traditional monitoring has changed, CROs should build a portfolio of remote access solutions and have them ready.Ryan Jones, CEO, Florence Healthcare 10.13.20
-
Drug Development
New York City is Not Dead, Our Life Sciences Sector is Thriving
Amid the COVID-19 pandemic, life sciences is booming in NYC!Sara Jane Demy, CEO & Founder, Demy-Colton 10.01.20
-
Facilities
The Changing Approach to Design: Five Ways to Achieve Warp Speed
Revisiting facility design and construction based on today’s biopharmaceutical industry needs.Jarrod Wrampe, Project Manager, CRB 09.30.20
-
Puerto Rico is Primed to Take Over the Biosciences World Stage – Here's Why
Is Puerto Rico the solution to reshoring pharmaceutical and medical equipment manufacturing stateside?Michael P. Gay, CEcD, Chief Business Development Officer, Invest Puerto Rico 09.24.20
-
Clinical Trials | Drug Development
How to Balance Internal and External Staff Within Outsourcing Models
Strategies to consider in flexed staffing models.John Barry, SVP, Consulting Practice and Chief Strategy Officer, PRA Health Sciences, SSD 09.22.20
-
Biologics, Proteins, Vaccines | Drug Development
The Importance of Global Collaboration in the Fight Against COVID-19
Industry continues to join forces to find new treatments for COVID-19.Dohyun Cho, Chief Operating Officer, Enzychem Lifesciences 09.08.20
-
Clinical Trials | Drug Development
FDA Response to COVID-19
A Discussion on Protocol Amendments and Clinical Study Reports in Affected Ongoing Trials.Jack Modell, M.D., Vice President and Senior Medical Officer, Rho 09.03.20
